Why the study?
Does atracurium differ from vecuronium in neuromuscular blockade and clinical outcomes in women undergoing laparoscopy?
Does atracurium differ from vecuronium in neuromuscular blockade and clinical outcomes in women undergoing laparoscopy?
Atracurium and vecuronium provide comparable clinical neuromuscular blockade for laparoscopy, though atracurium shows greater initial twitch depression and fade.
No difference after 2 minutes supports interchangeable use in laparoscopy; confirms comparable overall neuromuscular blockade with atracurium and vecuronium.
In a double-blind, prospective, randomised trial in 30 women undergoing laparoscopy, atracurium and vecuronium were compared in equipotent (2 X ED95) doses. In the atracurium group, first twitch depression was significantly greater at one minute, and degree of fade significantly greater at one and two minutes, but thereafter neuromuscular monitoring showed no significant difference between the groups. Clinically there was no significant difference between the drugs. Mild intraoperative hypotension was equally common in both groups as was sinus bradycardia. Reversal and recovery were comparable in the two groups. Neostigmine was required in all patients and in three (one atracurium, two vecuronium) a second dose was required in all patients and in three (one atracurium, two vecuronium) a second dose was administered on clinical grounds. Antagonism of the neuromuscular block is required with surgery of this duration despite the intermediate duration of action of the relaxant drugs.
No takes yet. Share an insight, caveat, or question.
Raynes et al. (1987) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: